EUVIMEDEUVIMED entdecken
Crossref

Genetic and Clinical Characteristics of 185 Japanese Children With 46,XY Differences of Sex Development

Mie Hayashi iD, Satoshi Narumi iD, Takeshi Sato iD, Naoko Amano iD, Ayuko Suzuki Suwanai, Hidenori Haruna, Koji Muroya iD, Masanori Adachi iD, Hiroshi Asanuma, Hirofumi Ohashi, Tomohiro Ishii iD, Tomonobu Hasegawa iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Mie Hayashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan. Hauptthemen laut MEDLINE: Disorder of Sex Development, 46,XY. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Health Science Research Grant for Research on Applying Health Technology, Ministry of Health, Labour, and Welfare, Japan, Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

46,XY differences of sex development (DSD) are heterogeneous in etiology. The detailed phenotypes of 46,XY DSD patients with monogenic disorders have not been fully elucidated.

Objectives

To estimate the proportion of monogenic disorders in 46,XY DSD and to characterize the clinical phenotypes of patients with monogenic disorders.

Methods

A total of 185 Japanese patients (178 families) were enrolled. We sequenced 25 genes related to 46,XY DSD and assessed the pathogenicity of the identified sequence variants according to the American College of Medical Genetics and Genomics guidelines, supplemented by in silico and/or in vitro analyses. We analyzed the clinical phenotypes of patients with monogenic disorders, with particular attention to the external or internal genitalia.

Results

We identified 51 patients (47 families) with any monogenic disorders (26%), who possessed pathogenic variants in AR (11%), SRD5A2 (4.5%), NR5A1 (4.0%), SRY (2.8%), WT1 (1.1%), STAR (1.1%), CYP17A1 (0.56%), HSD3B2 (0.56%), or MAP3K1 (0.56%). The proportion of monogenic disorders was significantly higher in subjects with detected Müllerian derivatives (57%) than in those undetected (26%) (P = .029), and in subjects with female-typical genitalia (91%) than in those with ambiguous genitalia (19%) (P < .001).

Conclusion

The proportion of monogenic disorders in Japanese 46,XY DSD patients was approximately 26%. Monogenic disorders were frequent among patients with severe undermasculinization of the external or internal genitalia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disorder of Sex Development, 46,XYAdolescentChildChild, PreschoolFemaleHumansInfantMaleJapanMutationPhenotypeEast Asian People

Stichwörter der Autor:innen

46,XYMüllerian derivativesambiguous genitaliadifferences of sex developmentgenetic disorder

Autor:innen und Institutionen

  • Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
  • Department of Pediatrics and Adolescent Medicine, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
  • Department of Endocrinology and Metabolism, Kanagawa Children's Medical Center, Yokohama 232-8555, Japan.
  • Department of Urology, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Division of Medical Genetics, Saitama Children's Medical Center, Saitama 330-8777, Japan.

ORCID-Profile: Mie Hayashi, Satoshi Narumi, Takeshi Sato, Naoko Amano, Koji Muroya, Masanori Adachi, Tomohiro Ishii, Tomonobu Hasegawa

Förderung

  • Health Science Research Grant for Research on Applying Health Technology
  • Ministry of Health, Labour, and Welfare, Japan
  • Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics
  • SANDOZ Research Grant
  • Eli Lilly and Company Ltd.
  • JCR Pharmaceuticals Co., Ltd
  • Novo Nordisk Pharma Ltd.

Zitieren

APA

Hayashi, M., Narumi, S., Sato, T., Amano, N., Suwanai, A. S., Haruna, H., Muroya, K., Adachi, M., Asanuma, H., Ohashi, H., Ishii, T., & Hasegawa, T. (2025). Genetic and Clinical Characteristics of 185 Japanese Children With 46,XY Differences of Sex Development. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae813

Vancouver

Hayashi M, Narumi S, Sato T, Amano N, Suwanai AS, Haruna H, et al. Genetic and Clinical Characteristics of 185 Japanese Children With 46,XY Differences of Sex Development. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae813

BibTeX
@article{Hayashi2025,
  author = {Hayashi, Mie and Narumi, Satoshi and Sato, Takeshi and Amano, Naoko and Suwanai, Ayuko Suzuki and Haruna, Hidenori and Muroya, Koji and Adachi, Masanori and Asanuma, Hiroshi and Ohashi, Hirofumi and Ishii, Tomohiro and Hasegawa, Tomonobu},
  title = {Genetic and Clinical Characteristics of 185 Japanese Children With 46,XY Differences of Sex Development},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae813}
}
Kostenlos starten →